- Home
- CCLD vs LXEO Comparison
CCLD vs LXEO Comparison
Compare CCLD & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- LXEO
- Stock Information
- Founded
- CCLD 1999
- LXEO 2017
- Country
- CCLD United States
- LXEO United States
- Employees
- CCLD N/A
- LXEO N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- LXEO
- Sector
- CCLD Technology
- LXEO
- Exchange
- CCLD Nasdaq
- LXEO Nasdaq
- Market Cap
- CCLD 105.8M
- LXEO 93.9M
- IPO Year
- CCLD 2014
- LXEO 2023
- Fundamental
- Price
- CCLD $2.32
- LXEO $4.12
- Analyst Decision
- CCLD Buy
- LXEO Strong Buy
- Analyst Count
- CCLD 2
- LXEO 5
- Target Price
- CCLD $3.00
- LXEO $16.60
- AVG Volume (30 Days)
- CCLD 473.8K
- LXEO 507.5K
- Earning Date
- CCLD 08-12-2025
- LXEO 08-11-2025
- Dividend Yield
- CCLD N/A
- LXEO N/A
- EPS Growth
- CCLD N/A
- LXEO N/A
- EPS
- CCLD N/A
- LXEO N/A
- Revenue
- CCLD $112,507,000.00
- LXEO N/A
- Revenue This Year
- CCLD $2.74
- LXEO N/A
- Revenue Next Year
- CCLD $7.52
- LXEO N/A
- P/E Ratio
- CCLD N/A
- LXEO N/A
- Revenue Growth
- CCLD N/A
- LXEO N/A
- 52 Week Low
- CCLD $1.14
- LXEO $1.45
- 52 Week High
- CCLD $4.84
- LXEO $15.31
- Technical
- Relative Strength Index (RSI)
- CCLD 49.37
- LXEO 50.02
- Support Level
- CCLD $2.35
- LXEO $4.40
- Resistance Level
- CCLD $2.48
- LXEO $4.85
- Average True Range (ATR)
- CCLD 0.12
- LXEO 0.31
- MACD
- CCLD -0.03
- LXEO -0.04
- Stochastic Oscillator
- CCLD 12.90
- LXEO 22.34
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.